Menlo Therapeutics Inc. (MNLO): Price and Financial Metrics
Menlo Therapeutics Inc. (MNLO)
Today's Latest Price: $4.36 USD
Updated Dec 13 12:00am
Add MNLO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 214 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
MNLO Stock Price Chart More Charts
MNLO Price/Volume Stats
| Current price | $4.36 | 52-week high | $9.03 |
| Prev. close | $4.42 | 52-week low | $2.69 |
| Day low | $4.22 | Volume | 101,700 |
| Day high | $4.50 | Avg. volume | 66,891 |
| 50-day MA | $4.56 | Dividend yield | N/A |
| 200-day MA | $5.59 | Market Cap | 104.57M |
Menlo Therapeutics Inc. (MNLO) Company Bio
Menlo Therapeutics Inc., a biopharmaceutical company, focuses on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions in the United States. The company has completed Phase II clinical trials in pruritus associated with prurigo nodularis. It is also developing products that are in Phase II clinical trials in pruritus associated with psoriasis and atopic dermatitis, and refractory chronic cough. The company was formerly known as Tigercat Pharma, Inc. and changed its name to Menlo Therapeutics Inc. in May 2016. Menlo Therapeutics Inc. was founded in 2011 and is based in Redwood City, California.
Top Stories View All
Best & Worst Performing Stock Industries for December 13, 2019
Best & Worst Performing Small Cap Stocks for December 13, 2019
Best & Worst Performing Mid Cap Stocks for December 13, 2019
Best & Worst Performing Large Cap Stocks for December 13, 2019
Best & Worst Performing Mega Cap Stocks for December 13, 2019
View All Top Stories
Loading social stream, please wait...